EpiCor Postbiotic Demonstrates Rapid Immune Biomarker Modulation
Trendline

EpiCor Postbiotic Demonstrates Rapid Immune Biomarker Modulation

What's Happening? A new clinical study has shown that EpiCor, a postbiotic, can produce measurable changes in immune-related biomarkers within three hours of consumption. Conducted by NIS Labs and Cargill, the study highlights the rapid onset of biological processes that contribute to EpiCor's benef
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.